title: Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
authors.forename: Peter
authors.initials: P
authors.lastname: Höfer
authors.forename: Fabian
authors.initials: F
authors.lastname: Friedrich
authors.forename: Benjamin
authors.initials: B
authors.lastname: Vyssoki
authors.forename: Christoph
authors.initials: C
authors.lastname: Spindelegger
authors.forename: Maria
authors.initials: M
authors.lastname: Schmook
authors.forename: Christian
authors.initials: C
authors.lastname: Barnas
authors.forename: Otto M
authors.initials: OM
authors.lastname: Lesch
authors.forename: Henriette
authors.initials: H
authors.lastname: Walter
mesh_terms: D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D000077152:Olanzapine; D010902:Pituitary Gland / Q000187:drug effects / Q000473:pathology; D010911:Pituitary Neoplasms / Q000139:chemically induced* / Q000175:diagnosis; D015175:Prolactinoma / Q000139:chemically induced* / Q000175:diagnosis; D011618:Psychotic Disorders / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D013973:Thyrotropin-Releasing Hormone; D013469:Sulpiride; D000077582:Amisulpride; D000077152:Olanzapine